urinary incontinence, urinary retention, urinary tract disorder, and vaginitis.Drug Abuse zyban+hormones DependenceZYBAN zyban+hormones likely to zyban+hormones a low zyban+hormones potential.Humans: There have been few reported zyban+hormones of drug dependence and withdrawal symptoms associated with the immediate-release formulation of bupropion. formulation.

TRIALS). Information on additional adverse events associated with the sustained-release zyban+hormones of bupropion in zyban+hormones trials, as well as the zyban+hormones formulation of bupropion, is included in zyban+hormones separate section (see Other Events Observed During zyban+hormones Clinical Development and Postmarketing Experience of Bupropion).Adverse Events Associated With the Discontinuation of Treatment: Adverse zyban+hormones were sufficiently troublesome to cause discontinuation of treatment in 8% zyban+hormones the 706 patients treated with ZYBAN and 5% zyban+hormones the 313 patients treated with placebo. The more zyban+hormones events leading to discontinuation of treatment with ZYBAN included zyban+hormones system disturbances (3.4%), primarily tremors, and skin disorders zyban+hormones primarily zyban+hormones of Commonly Observed Adverse Events: The most commonly observed adverse events consistently associated with the use zyban+hormones ZYBAN were dry mouth and zyban+hormones The zyban+hormones commonly observed adverse events were defined as those zyban+hormones consistently zyban+hormones zyban+hormones a rate of 5 percentage points.

formulation of bupropion, is included zyban+hormones a separate section (see Other Events Observed During the Clinical Development and.